Leena Peltonen-Palotie (16 June 1952 – 11 March 2010[4]) was a Finnish geneticist who contributed to the identification of 15 genes for Finnish heritage diseases, including arterial hypertension, schizophrenia, lactose intolerance, arthrosis and multiple sclerosis.
She completed her secondary education at the Finnish Co-educational Lycée of Oulu, graduating in 1971.
In April 2005 Peltonen-Palotie was employed at the University of Helsinki and the National Public Health Institute of Finland.
In 2004 she became a member of the Board of Directors of Orion Corporation, the largest Finnish pharmaceutical company.
In September 2007, Peltonen-Palotie joined the Wellcome Trust Sanger Institute as the head of Human Genetics.